Posted on August 21, 20258/21/25
Redefining CAR-T Access: Strategic Implications of the FDA’s REMS Decision
Posted on September 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on October 10, 202310/10/23
Lead Time Is All You Need: Patient Identification for Cell and Gene Therapies Using Machine Learning and Advanced Data Analytics
Posted on August 21, 20238/21/23
Maximizing Potential: Essential Steps for Successful Commercialization of Cell and Gene Therapies
Posted on June 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on June 13, 20236/13/23